17. Bup-nalox vs. Bup in Pregnancy17. Bup-nalox vs. Bup in Pregnancy
Addiction Medicine Journal Club
Explore buprenorphine treatments for opioid use disorder in pregnancy, plus discussions on psilocybin legalization and opioid-induced urinary retention.
35:23•27 Feb 2023
Pregnancy and Opioid Use Disorder: A Closer Look at Buprenorphine Treatments
“We know that there is a lot of art to this right. How's it accounted for, like who receives what drug, if they're all occurring simultaneously, since kind of severity and clinical situation?”
Ever wondered how opioid treatments stack up during pregnancy? In this episode of the 'Addiction Medicine Journal Club', Dr. Sonya Del Tredici and Dr. John Keenan tackle the pressing topic of buprenorphine-naloxone versus buprenorphine alone for opioid use disorder in expectant mothers. They dive into a recent study published in the Journal of Addiction Medicine, exploring the effectiveness and safety of these treatments. But that's not all.
The hosts also delve into opioid-induced urinary retention and the intriguing legalization of psilocybin in Oregon for treating alcohol use disorder and depression. Drs. Del Tredici and Keenan don't shy away from discussing the standard of care for maternal opioid use disorder, neonatal opioid withdrawal syndrome, and the hurdles of prior authorization for buprenorphine.
They shed light on patient-centered outcomes and potential industry biases, making this episode a must-listen for anyone involved in addiction medicine or simply curious about these critical issues. Wrapping up on a hopeful note, they highlight the growing evidence supporting the safety of both medications during pregnancy. Tune in for an engaging and informative discussion that could reshape your understanding of addiction treatment during pregnancy.
Do you want to link to this podcast?
Get the buttons here!
More From This Show
The latest episodes from the same podcast.
Related Episodes
Similar episodes from other shows in the catalogue.